Please login to the form below

Not currently logged in
Email:
Password:

Takeda UK

This page shows the latest Takeda UK news and features for those working in and with pharma, biotech and healthcare.

Takeda and SportInspired launch Active Communities, Brighter Future

Takeda and SportInspired launch Active Communities, Brighter Future

Takeda and SportInspired launch Active Communities, Brighter Future. The UK initiative will improve children's physical and mental wellbeing. ... Adam Zaeske, managing director of Takeda UK and Ireland, said: “Takeda and SportInspired share the same

Latest news

  • Takeda can't sway NICE on oral myeloma therapy Ninlaro Takeda can't sway NICE on oral myeloma therapy Ninlaro

    Commenting on NICE's decision, Adam Zaeske, managing director of Takeda UK and Ireland, said: " We felt that our proposed confidential offer addressed the uncertainties NICE had in the first ACD, ... standard in myeloma treatment and patients in the UK

  • NICE reverses stance on Takeda’s Adcetris NICE reverses stance on Takeda’s Adcetris

    NICE reverses stance on Takeda’ s Adcetris. But firm criticises final draft guidance's new restrictions on the non-Hodgkin’s lymphoma drug. ... Takeda UK’s general manager Adam Zaeske said: “We are pleased with the positive NICE decision, however,

  • Havas Lynx excels at PM Society Awards Havas Lynx excels at PM Society Awards

    Aurora Healthcare Communications won the target award for corporate communications on behalf of Takeda UK's Entyvio brand, for its 'Bringing a patient support programme to life' campaign targeting HCPs. ... Target Award for Corporate Communications -

  • Takeda: No decision yet on shutdown of Cambridge, UK unit Takeda: No decision yet on shutdown of Cambridge, UK unit

    Takeda: No decision yet on shutdown of Cambridge, UK unit. Tells PMLiVE that consultation over proposed closure of R&D site still ongoing. ... Takeda says the consultation over the proposed closure of its operations in Cambridge, UK is continuing with no

  • NICE turns down CDF drug Adcetris in draft guidance NICE turns down CDF drug Adcetris in draft guidance

    NICE turns down CDF drug Adcetris in draft guidance. Takeda’ s treatment for Hodgkin’ s lymphoma not seen to be cost-effective. ... Brentuximab vedotin has been a game changer in the management of relapsed or refractory Hodgkin lymphoma and is the

More from news
Approximately 0 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • Japanese pharma pulls no punches with post-Brexit UK Japanese pharma pulls no punches with post-Brexit UK

    Takeda - notes that all its members conduct R&D in the UK and over £60m was invested by them directly in the country last year. ... It also recently launched neuroscience company Cerevance in Cambridge, Massachusetts in partnership with Lightstone

  • Deal Watch October 2016 Deal Watch October 2016

    Branded products. $600m royalties. $230m US. 2.6. Respiratory 2015. Takeda. Daxas Non US. ... Asset Acquisition. Pet vaccines in US. 885. Crescendo (UK). Takeda (JP).

  • Case study: Treatment guidance Case study: Treatment guidance

    Client:Takeda UK. Agency:Liberation Communications. Campaign:A Practical Guide to using Mepact (mifamurtide). ... Takeda UK wanted to support HCPs by providing a simple Practical Guide that enabled them to administer mifamurtide confidently and

  • Case study: Treatment guidance Case study: Treatment guidance

    Client:Takeda UK. Agency:Liberation Communications. Campaign:A Practical Guide to using Mepact (mifamurtide). ... Takeda UK wanted to support HCPs by providing a simple Practical Guide that enabled them to administer mifamurtide confidently and

  • Interview: Trevor Smith, Takeda Interview: Trevor Smith, Takeda

    Interview: Trevor Smith, Takeda. Takeda’ s head of commercial operations for Europe and Canada talks about the integration of Nycomed and European market access. ... Vice President, New Portfolio. Takeda Pharmaceuticals Europe. Managing Director,

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland appoints market access director. Peter Wheatley Price brings experience from GSK, Janssen and Boehringer Ingelheim. ... Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to

  • Takeda appoints UK & Ireland digital lead Takeda appoints UK & Ireland digital lead

    Takeda UK &Ireland has appointed Marc Weeks to the newly-created position of digital lead. ... With rich previous experience working on digital pharmaceutical projects, Marc will fill a knowledge gap at Takeda UK that is instrumental to the company

  • Ashfield Healthcare expands its board of directors Ashfield Healthcare expands its board of directors

    Most recently, she served as head of operations for Ashfield's UK business. ... Frater currently serves as national sales manager for the Takeda UK account.

  • Takeda UK adds to its senior leadership team Takeda UK adds to its senior leadership team

    Takeda UK adds to its senior leadership team. Simon Meadowcroft and Pauline Bromley join the firm . ... Takeda UK has added new names to its senior team with the appointment of a new medical director and human resources director.

  • Adam Zaeske appointed as new MD of Takeda UK Adam Zaeske appointed as new MD of Takeda UK

    Adam Zaeske appointed as new MD of Takeda UK. Promoted after 11 years with the company. ... Takeda UK has appointed Adam Zaeske as its new managing director of Takeda UK and Ireland.

More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics